Spinal muscular atrophy type 2

We’re all in this for good.

By sharing your stories and data, you will:
  • help each other live better and uncover the best ways to manage your health today
  • help researchers shorten the path to new treatments tomorrow

How much good can your data do? A whole lot, as co-founder Jamie Heywood explains in this video.

What is spinal muscular atrophy type 2?

Spinal Muscular Atrophy Type 2 is an inherited (genetic) condition that affects the nerve cells (motor neurons) in your spinal cord. The nerve cells tend to impair the legs more than arms. Onset of this condition is usually from 6 to 18 months of age.

Common symptoms reported by people with spinal muscular atrophy type 2

Common symptoms
How bad it is
What people are taking for it

Reports may be affected by other conditions and/or medication side effects. We ask about general symptoms (anxious mood, depressed mood, fatigue, pain, and stress) regardless of condition.
Last updated:

Treatments taken by people with spinal muscular atrophy type 2

Treatment name(s)
Type
How many have tried
Tried for
Treatment name(s)

(Klonopin)
Type
Prescription Drug
How many have tried
1
Tried for
anxious mood (1)

Data from patients with spinal muscular atrophy type 2, who reported starting treatments within the last 5 years.
Last updated:

Compare treatments taken by people with spinal muscular atrophy type 2

Treatment name(s)
Perceived effectiveness
Side effects
Total evaluations
Tried for
Treatment name(s)

(Klonopin)
Perceived effectiveness
for anxious mood (1 evaluation)
Side effects
Total evaluations
1
Tried for
anxious mood (1)
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
  • Severe
  • Moderate
  • Mild
  • None

Data from patients with spinal muscular atrophy type 2, who reported starting treatments within the last 5 years.
Last updated:

Who has spinal muscular atrophy type 2 on PatientsLikeMe?


Age
Age Proportion # of patients
<20 6
20s 7
30s 8
40s 4
50s 5
60s 2
70+ 2
Age at first symptom
Age at first symptom Proportion # of patients
0-19 years 11
20-29 years 1
30-39 years 0
40-49 years 0
50-59 years 0
60-69 years 0
70+ years 0

Distribution of sex

Sex
Sex Proportion # of patients
Male 11
Female 25

Diagnosis status
Diagnosis status Proportion # of patients
Diagnosed 15
Not Diagnosed 1

These charts show data from spinal muscular atrophy type 2 patients who have completed their condition history
Last updated: